Con is a senior healthcare communicator with over 18 years’ agency experience in leading corporate reputation, brand and issues readiness programmes for some of the biggest names in global medicine.
From 2011 to 2014 he led global communication strategy for Bayer and its flagship pharmaceutical Xarelto®from its phase III program to launch in the product’s first four antithrombotic indications, alongside the development of a comprehensive issues readiness protocol for management of potential safety and AE challenges. He also acted as the global-to-local communications link between Bayer’s German HQ and its UK affiliate business.
Across 2015-2016, Con led major workstreams for the EU pharmaceutical trade body EFPIA on outcomes-driven sustainable healthcare and defending the European pharma industry’s position on the price of medicines. Further healthcare comms experience includes worldwide virology communication strategy for AbbVie, global brand planning for Pfizer’s neuropathic pain brand Lyrica®, and extensive work with Shire for several years delivering worldwide data communication, KOL and brand strategy for its orphan and rare disease portfolio. Con has created reputation-boosting programmes for leading academic institutions including Harvard Medical School and the premier Swiss university EPFL, bringing their respective gene therapy, neuroscience and neuroengineering research breakthroughs to a wide global audience of media, investors and commercialisation partners.
He is a 2019 Communiqué Healthcare Awards Judge and a guest lecturer on healthcare communications at Imperial College London.
Forget sweating onions, in 2019 a good comms strategy is all about sweating your assets. I don’t want to stretch the analogy past its boiling point, but delivering good communications strategies often feels like you’re standing at the kitchen worktop with a bunch of fantastic, high quality, ingredients and the challenge is to create the […]